Key player · Company profile

Regeneron Pharmaceuticals

Named as a key player in 33 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Diabetic Retinopathy Drugs (India) 9%

Where they show up

  • Pharmaceuticals33

Geographies

Regeneron Pharmaceuticals's markets

Markets where Regeneron Pharmaceuticals is a key player, with the world market size
MarketCategoryWorld 2023CAGR
Diabetic Retinopathy Drugs Pharmaceuticals$10.8 Bn6%

Companies they compete with most

Named as key players in the same markets as Regeneron Pharmaceuticals (number of shared markets).

AbbVie Inc.1 shared market Alimera Sciences1 shared market Allergan (AbbVie Inc.)1 shared market Ampio Pharmaceuticals.1 shared market Bayer AG1 shared market Genentech Inc.1 shared market Novartis AG1 shared market Roche Holding AG.1 shared market

Recent reports naming Regeneron Pharmaceuticals

Search all reports for Regeneron Pharmaceuticals All companies